CTOs on the Move

RaNA Therapeutics

www.ranarx.com

 
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.ranarx.com
  • 790 Memorial Dr Ste 203
    Cambridge, MA USA 02139
  • Phone: 617.945.7361

Executives

Name Title Contact Details

Funding

RaNA Therapeutics raised $55M on 07/23/2015
RaNA Therapeutics raised $51M on 01/11/2017

Similar Companies

Veran Medical Technologies

Veran Medical Technologies, Inc., an image guided medical device company, develops a suite of products to enable physicians to diagnose disease and deliver therapies. It offers standards for minimally invasive delivery of interventional oncology therapies. The company provides plug-n-play delivery systems and navigated instruments. Its IG4 Platform allows clinicians to visualize various types of information integrated with a CT dataset, such as respiration, contrast enhanced structures, PET, and ultrasound. The company also provides SPiN Drive System that acts as a GPS-like system to enable pulmonologists and surgeons to access peripheral solitary pulmonary nodules to diagnose malignancy. Veran Medical Technologies, Inc. was incorporated in 2007 and is headquartered in St. Louis, Missouri.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.

Aptuit Informatics

Aptuit Informatics is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carolina Centers for Medical Excellence

Carolina Centers for Medical Excellence is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioCentury Publications

BioCentury Publications, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. BioCentury Publications, Inc. is based in Redwood City, CA. You can find more information on BioCentury Publications, Inc. at www.biocentury.com